Spelling suggestions: "subject:"catecholmethyltransferase"" "subject:"adenosylmethyltransferase""
1 |
Biological significance, oxidative inhibition, and glutathiolation of human soluble catechol-O-methyltransferase /Cotton, Naomi Johanna Helen. January 2004 (has links)
Thesis (Ph. D.)--University of Washington, 2004. / Vita. Includes bibliographical references (leaves 58-71).
|
2 |
The magnetoencephalographic signature of catechol-O-methyltransferaseFarrell, Sarah Marie January 2013 (has links)
Catechol-O-methyltransferase (COMT) metabolizes catechols, notably dopamine. The COMT Val158Met polymorphism influences its enzyme activity, and multiple neural correlates of this genotype on dopaminergic phenotypes have been reported, particularly with regards to working memory. COMT activity can also be regulated pharmacologically by COMT inhibitors. The ‘inverted-U’ relationship between dopamine signalling and cognitive performance predicts that the effects of COMT inhibition will differ according to COMT genotype. The goal of this thesis was to better understand COMT’s impact on brain function and behaviour. Here, 33 subjects homozygous for COMT Val158 (‘Val homozygotes’) and 34 homozygous for COMT Met158 (‘Met homozygotes’) were randomly assigned, double-blind, to a single dose of the brain-penetrant COMT inhibitor tolcapone (200mg) or placebo. They completed the N-back task of working memory, an emotional face processing task, and a gambling task, in a magnetoencephalography (MEG) scanner, allowing both behavioural performance and neural activity to be investigated. The data presented in this thesis confirm that COMT activity influences performance on, and neural activity during, the N-back task, in a way consistent with the inverted-U model of dopamine function. The effect on risky decision making is novel, and indicates that COMT plays roles in domains beyond working memory, and that such domains may also follow an inverted-U. Neural activity during the faces task and the gambling task also show COMT-modulated differences. The behavioural results show that the direction of effect of a drug can be influenced by sequence variation in its target gene. They are of translational relevance, since COMT inhibitors are used in the adjunctive treatment of Parkinson’s disease and are under evaluation in schizophrenia and other disorders. The MEG data show that for the three tasks, there are effects of Val158Met genotype, of tolcapone, and their interaction, on neural activity (for example, the P300 during N-back), revealing a complex temporal and spatial pattern which sheds some light on the neural processing underlying these tasks and their previously reported fMRI correlates.
|
3 |
Computational studies of protein stabilization and denaturation by small molecules /Bennion, Brian James. January 2003 (has links)
Thesis (Ph. D.)--University of Washington, 2003. / Vita. Includes bibliographical references (leaves 183-205).
|
4 |
Crystallographic studies on drug receptors catechol O-methyltransferase and carbonic anhydrase /Vidgren, Jukka. January 1994 (has links)
Thesis (doctoral)--Lund University, 1994. / Added t.p. with thesis statement inserted.
|
5 |
Crystallographic studies on drug receptors catechol O-methyltransferase and carbonic anhydrase /Vidgren, Jukka. January 1994 (has links)
Thesis (doctoral)--Lund University, 1994. / Added t.p. with thesis statement inserted.
|
6 |
Contributions of COMT and DAT to regulation of phasic dopamine release and reward-guided behaviourKorn, Clio January 2016 (has links)
Fine temporal regulation of dopamine transmission is critical to its effects on behaviour. Dopamine can be cleared from the synapse either by recycling via the dopamine transporter (DAT) or by enzymatic degradation involving catechol-O-methyltransferase (COMT). DAT recycling predominates in striatum and contributes to dopaminergic regulation of reward-guided behaviour, while COMT degradation predominates in cortex and modulates executive functions. However, human functional imaging studies demonstrate interactive effects of DAT and COMT genotype, suggesting that the traditional division between DAT and COMT is not so clear-cut. Given the interdependence of mesolimbic and mesocortical circuitry and the presence of COMT in the striatum, it is possible that DAT and COMT interact to a greater extent than previously thought. We investigated the contributions of DAT and COMT to regulation of dopamine transmission and reward-guided behaviour by combining in vivo electrochemical recording, pharmacology, and behavioural testing in mice. Using fast scan cyclic voltammetry to record evoked dopamine release in anaesthetised animals, we found that systemic DAT blockade increased the size of dopamine transients in the nucleus accumbens (NAc) but not in the medial frontal cortex (MFC), demonstrating that DAT regulates phasic striatal dopamine release and confirming that DAT makes little contribution to regulation of cortical dopamine transmission. Unexpectedly, COMT inhibition did not affect evoked dopamine transients in either the NAc or the MFC. In agreement with these findings, systemic administration of a DAT blocker, but not of a COMT inhibitor, increased motivation to work for reward in a progressive ratio paradigm. COMT inhibition also had little effect on reinforcement learning (RL) strategies during reward-guided decision making. Intriguingly, however, we found that DAT blockade both decreased the influence of model-free RL and increased the influence of model-based RL on behaviour. Our study confirms that DAT regulates dopamine transmission in striatum but not in cortex and indicates that sub-second changes in dopamine transmission in both regions are largely insensitive to COMT. However, our behavioural data reveal the importance of striatal dopamine in multiple components of reward-guided behaviour, including both motivational aspects traditionally associated with striatum as well as cognitive aspects heretofore mainly associated with cortical function. Together, these findings emphasise that reward processing occurs across corticostriatal circuits and contribute to our understanding of how striatal dopamine transmission regulates reward-guided behaviours.
|
7 |
Catecol O-metiltransferase e o transtorno obsessivo-compulsivo: revisão sistemática com meta-análise / Catechol O-metyltransferase and obsessive-compulsive disorder: systematic review and meta-analysisAline Santos Sampaio 05 September 2012 (has links)
INTRODUÇÃO: O caráter familial do transtorno obsessivo-compulsivo (TOC) já é bem estabelecido. O gene da catecol O-metiltransferase (COMT) vem sendo objeto de estudo na genética de transtornos mentais, como o TOC. No caso deste transtorno, os resultados de estudos de associação com o gene da COMT são, em sua maioria, contraditórios. Meta-análises prévias, todas elas conduzidas com limitações metodológicas, encontraram achados também divergentes. Nesta tese, foram realizadas: uma revisão sistemática da literatura sobre estudos de associação baseados em famílias envolvendo o polimorfismo Val158Met do gene da COMT e o TOC e duas meta-análises, uma convencional e outra bayesiana, a fim de sintetizar os achados sobre este tema. MÉTODOS: Este trabalho seguiu o protocolo para revisão sistemática e meta-análise da Rede de Epidemiologia Genética Humana (HuGE). A busca por estudos de associação baseados em famílias foi feita em cinco bases de dados eletrônicas, assim como foram pesquisados estudos não publicados, dentre os quais um estudo ainda inédito, liderado pela autora desta tese. A meta-análise convencional foi calculada com o auxílio do programa STATA V. 11 e a bayesiana a partir da média das verossimilhanças. Foram investigados os viéses de publicação, heterogeneidade, além de análise de sensibilidade e metarregressão. RESULTADOS: O estudo original, que contou com 83 trios, conduzido pela autora desta tese, não encontrou associação entre COMT e TOC. Este estudo, em conjunto com mais oito estudos (seis estudos publicados e dois não publicados), foram incluídos na meta-análise. As meta-análises com método convencional e bayesiano não encontraram associação entre o polimorfismo Val158Met do COMT e o TOC na amostra total, nem nas amostras separadas por gênero. CONCLUSÕES: Contrariando meta-análises prévias, os achados deste estudo não demonstraram associação entre COMT e TOC. No entanto, a participação do gene da COMT em subgrupos específicos do TOC e em seus endofenótipos de risco ainda merece ser investigada / BACKGROUND: Obsessive-compulsive disorder (OCD) has long been considered a familial disorder. The catechol-O-methyltransferase gene has been studied in several mental disorders, including OCD. Particularly in this disorder, the findings of an association between COMT and OCD are inconclusive. Previous meta-analyses, which were conducted with several methodological limitations, found conflicting results. This work comprises: a systematic literature review regarding family-based association studies involving the COMT Val158Met polymorphism and OCD, and two metaanalyses, a conventional and a Bayesian meta-analysis, to summarize the findings on this subject. METHODS: This study was performed according to the Human Genome Epidemiology network (HuGE) guidelines for systematic review and meta-analysis. The search for family-based association studies were conducted in five electronic databases and in sources from unpublished studies. An original unpublished study, led by the author of this thesis, was included in the meta-analysis. The conventional meta-analysis was calculated with the STATA V.11 software and the Bayesian meta-analysis through the likelihood mean. Publication bias and heterogeneity were investigated. Sensitivity analysis and meta-regression were also performed. RESULTS: The original study with 83 OCD trios, conducted by the author of this thesis, found no association between COMT and OCD. This study, together with eight other studies (six studies being published and two unpublished), were included in the meta-analysis. Meta-analyses with the conventional and Bayesian method found no association between the COMT Val158Met polymorphism and OCD in the total, female-only or male-only samples. CONCLUSIONS: Different from previous meta-analyses, this study does not support the association between COMT and OCD. However, the involvement of the COMT gene in specific subgroups of OCD or endophenotypes associated with a risk for OCD should be further investigated
|
8 |
Catecol O-metiltransferase e o transtorno obsessivo-compulsivo: revisão sistemática com meta-análise / Catechol O-metyltransferase and obsessive-compulsive disorder: systematic review and meta-analysisSampaio, Aline Santos 05 September 2012 (has links)
INTRODUÇÃO: O caráter familial do transtorno obsessivo-compulsivo (TOC) já é bem estabelecido. O gene da catecol O-metiltransferase (COMT) vem sendo objeto de estudo na genética de transtornos mentais, como o TOC. No caso deste transtorno, os resultados de estudos de associação com o gene da COMT são, em sua maioria, contraditórios. Meta-análises prévias, todas elas conduzidas com limitações metodológicas, encontraram achados também divergentes. Nesta tese, foram realizadas: uma revisão sistemática da literatura sobre estudos de associação baseados em famílias envolvendo o polimorfismo Val158Met do gene da COMT e o TOC e duas meta-análises, uma convencional e outra bayesiana, a fim de sintetizar os achados sobre este tema. MÉTODOS: Este trabalho seguiu o protocolo para revisão sistemática e meta-análise da Rede de Epidemiologia Genética Humana (HuGE). A busca por estudos de associação baseados em famílias foi feita em cinco bases de dados eletrônicas, assim como foram pesquisados estudos não publicados, dentre os quais um estudo ainda inédito, liderado pela autora desta tese. A meta-análise convencional foi calculada com o auxílio do programa STATA V. 11 e a bayesiana a partir da média das verossimilhanças. Foram investigados os viéses de publicação, heterogeneidade, além de análise de sensibilidade e metarregressão. RESULTADOS: O estudo original, que contou com 83 trios, conduzido pela autora desta tese, não encontrou associação entre COMT e TOC. Este estudo, em conjunto com mais oito estudos (seis estudos publicados e dois não publicados), foram incluídos na meta-análise. As meta-análises com método convencional e bayesiano não encontraram associação entre o polimorfismo Val158Met do COMT e o TOC na amostra total, nem nas amostras separadas por gênero. CONCLUSÕES: Contrariando meta-análises prévias, os achados deste estudo não demonstraram associação entre COMT e TOC. No entanto, a participação do gene da COMT em subgrupos específicos do TOC e em seus endofenótipos de risco ainda merece ser investigada / BACKGROUND: Obsessive-compulsive disorder (OCD) has long been considered a familial disorder. The catechol-O-methyltransferase gene has been studied in several mental disorders, including OCD. Particularly in this disorder, the findings of an association between COMT and OCD are inconclusive. Previous meta-analyses, which were conducted with several methodological limitations, found conflicting results. This work comprises: a systematic literature review regarding family-based association studies involving the COMT Val158Met polymorphism and OCD, and two metaanalyses, a conventional and a Bayesian meta-analysis, to summarize the findings on this subject. METHODS: This study was performed according to the Human Genome Epidemiology network (HuGE) guidelines for systematic review and meta-analysis. The search for family-based association studies were conducted in five electronic databases and in sources from unpublished studies. An original unpublished study, led by the author of this thesis, was included in the meta-analysis. The conventional meta-analysis was calculated with the STATA V.11 software and the Bayesian meta-analysis through the likelihood mean. Publication bias and heterogeneity were investigated. Sensitivity analysis and meta-regression were also performed. RESULTS: The original study with 83 OCD trios, conducted by the author of this thesis, found no association between COMT and OCD. This study, together with eight other studies (six studies being published and two unpublished), were included in the meta-analysis. Meta-analyses with the conventional and Bayesian method found no association between the COMT Val158Met polymorphism and OCD in the total, female-only or male-only samples. CONCLUSIONS: Different from previous meta-analyses, this study does not support the association between COMT and OCD. However, the involvement of the COMT gene in specific subgroups of OCD or endophenotypes associated with a risk for OCD should be further investigated
|
9 |
The COMT p.Val158Met Polymorphism and Cognitive Performance in Adult Development, Healthy Aging and Mild Cognitive ImpairmentDegen, Christina, Zschocke, Johannes, Toro, Pablo, Sattler, Christine, Wahl, Hans-Werner, Schönknecht, Peter, Schröder, Johannes 10 August 2022 (has links)
Background: The impact of genetic polymorphisms on cognition is assumed to increase with
age as losses of brain resources have to be compensated for. We investigate the relation of
catechol-O-methyltransferase (COMT) p.Val158Met polymorphism and cognitive capacity in
the course of adult development, healthy aging and the development of mild cognitive impairment
(MCI) in two birth cohorts of subjects born between 1930 and 1932 or between 1950
and 1952. Methods: Thorough neuropsychological assessment was conducted in a total of
587 participants across three examination waves between 1993 and 2008. The COMT genotype
was determined as a restriction fragment length polymorphism after PCR amplification
and digestion with Nla III. Results: Significant effects of the COMT p.Val158Met polymorphism
were identified for attention and cognitive flexibility in the younger but not the older cohort.
Conclusion: These results confirm the importance of the COMT p.Val158Met genotype on
tasks assessing attention and cognitive flexibility in midlife but not in healthy aging and the
development of MCI. Our findings suggest that the influence of COMT changes as a function
of age, decreasing from midlife to aging.
|
10 |
Catechol-O-Methyltransferase (COMT) Val 108158 Met polymorphism and ADHD : pharmaco-behavioural genetic and neurocognitive studyChoudhry, Zia Ulhaq. January 2008 (has links)
The catechol-O-methyltransferase (COMT) gene is the predominant means of dopamine deactivation within the prefrontal cortex (PFC), a brain locus implicated in Attention deficit/hyperactivity disorder (ADHD). Dopamine dysregulation is a significant contributor to the pathophysiology of ADHD and Methylphenidate (MPH), an effective treatment for ADHD, and acts at least in part, through modulation of dopamine levels in the PFC. Thus, we tested the hypothesis that the Catechol-O-Methyltransferase (COMT) Val108/158 Met polymorphism modulates behavioral dimensions relevant for ADHD and/or response of these behavioral dimensions to MPH and/or neuropsychological functions considered relevant for ADHD. No genotype or genotype by treatment interaction effects were observed for behavioral response to MPH. No genotype effects were observed using the family-based approach. Marginal genotype effects were observed between the Met/Met genotype and some but not all aspects of executive functioning. Overall, these results do not support the implication of the COMT Val108/158 Met polymorphism in ADHD, ADHD relevant behaviours or response to methylphenidate, but weakly implicate COMT gene in some aspects of executive functions in children with ADHD. Given that gene effects on behaviours are likely to be very small, a much large sample would be needed in order to establish these results, both negative and positive, with better confidence.
|
Page generated in 0.0986 seconds